When the Kentucky Cabinet for Family and Health Services put out a call for ideas to improve access to evidence-based treatment for opioid use disorder (OUD), Drs. Laura Fanucchi, Michelle Lofwall and Sharon Walsh submitted a proposal.
The four-year, more than $87 million study has an ambitious but profoundly important goal: reducing opioid overdose deaths by 40 percent in 16 counties that represent more than a third of Kentucky’s population.
Linda Van Eldik, director of the UK Sanders-Brown Center on Aging, received $5.5 million from NIH and the Alzheimer's Drug Discovery Foundation. She developed a drug that is ready for its first round of testing in humans.
For International Women's Day and Women's History Month, we are highlighting women of UK. Researcher and Appalachian Kentucky native Michele Staton has a passion to help incarcerated women struggling with substance abuse.
Erin Calipari, an assistant professor in the Department of Pharmacology at Vanderbilt University, recently visited the University of Kentucky to give a talk about her work in addiction research.
A University of Kentucky study published in the Journal of the American College of Surgeons shows a direct link between the adoption of the Affordable Care Act (ACA) Medicaid expansion and the impact of colon cancer on Kentuckians.
UK researchers Jeramiah Smith and Randal Voss have assembled the entire genome of the Mexican Axolotl, a salamander that is key to unlocking the secrets of regeneration with potential for life-changing clinical applications down the road.
With funds from DOE, DOD and NSF, Jim Hower and Jack Groppo are locating and evaluating rare earth elements and processing coal-based materials, alongside industry and university partners.
Since 1981, with continuous funding from NSF and NASA, UK astronomer Gary Ferland has used computing to better understand our universe. He developed Cloudy, a computer code that predicts how light is emitted so scientists can interpret the light received from celestial bodies.
